Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

IPO grosses €97.75mm for Movetis NV

Executive Summary

Belgian biotech Movetis NV (focused on gastrointestinal disorders) has grossed €97.75mm ($147mm) through its initial public offering of 7.9mm shares at €12.25 each (including the overallotment). The shares were originally priced to sell at between €11.25 and €14.25. The company will trade on Euronext Brussels under the ticker MOVE.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies